Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the USA, and has major physical and psychological consequences including fear, anxiety and stigma. To date, there is no measure of health-related quality of life specifically designed to assess symptoms and functioning for people with cervical dysplasia resulting from HPV infection. In the present study, we set out to develop a disease-specific measure of health-related quality of life among women with low-grade cervical dysplasia. We conducted literature reviews, open-ended interviews with patients, clinician surveys and cognitive interviews which guided item development. The result is a preliminary 36-item measure, the Functional Assessment of Chronic Illness Therapy -Cervical Dysplasia (FACIT-CD), which sets out to assess the physical and psychological health-related quality-of-life aspects of cervical dysplasia and will be validated in an upcoming study.
INTRODUCTION
Recent data indicate that genital human papillomavirus (HPV) infections are the most common sexually transmitted infection in the USA, with an estimated prevalence of 28% for highand low-risk types among women in the USA between 14 and 59 years. 1 Of concern to women with cervical dysplasia related to HPV infection is its association with invasive cervical cancer, a cancer estimated to account for 12% of all cancers among women worldwide. 2 Psychosocial and quality-of-life research has shown that HPV infection and abnormal Papanicolaou tests (Pap smears) are associated with fear and anxiety, even among women with precancerous cervical dysplasia. 3, 4 Women who receive abnormal Pap results report fear of future reproductive impairment, cervical cancer and associated procedures. 5, 6 The anxiety reported by these women also includes concern about disclosing information to partners, families and friends due to stigma, 5 and concerns about transmission and sexual relationships. 6 Altered selfimage, as represented by feeling shame, guilt, self-blame, decreased self-esteem and negative body image, is another theme frequently reported by these women. 5 -8 HPV-positive women also report negative impact on feelings about sex, sexual activity and sexual enjoyment. 6, 7 Measures used to assess quality of life and symptoms associated with cervical dysplasia and HPV infection are few, and have included psychological distress and non-disease specific measures of quality of life. 3, 9, 10 While these and other general quality-of-life measures are available to assess patient outcomes, there is a need for a targeted index that can provide a precise evaluation of quality of life, physical symptoms and psychosocial distress associated with cervical dysplasia. In this study, we set out to develop a disease-specific measure of health-related quality of life, which included assessment of both physical and psychological functioning associated with cervical dysplasia.
METHODS
We used a multistep process to develop the disease-specific measure of quality of life. Our methods were consistent with the Patient Reported Outcomes Measurement Information System (PROMIS) initiative and Functional Assessment of Chronic Illness Therapy (FACIT) system, which prioritize information gathered from patients to guide instrument development. 11, 12 The FACIT system is family of instruments which began with the Functional Assessment for Cancer Therapy (FACT). Although the FACIT library has 'chronic illness' in its title because of its origins in cancer assessment, the library has expanded to include infectious diseases such as the Functional Assessment for HIV Infection (FAHI). Our instrument development process involved reviewing the literature for measurement studies in HPV, conducting open-ended interviews with women diagnosed with cervical dysplasia, surveying clinicians practicing in the area of gynaecological oncology on the appropriateness of draft items gathered from literature review and the FACIT questionnaire item database, conducting cognitive interviews, and refining items based on participant feedback.
Participants
For open-ended and cognitive interviews, participants were recruited from the colposcopy clinic of a community hospital in an affluent suburb in the midwestern region of the USA. Participants provided informed consent before completing study interviews. Participants were women who attended a gynaecological oncology clinic, over 18 years of age, with evidence of cervical infection positive for HPV. A physician determined each participant to have one of the following: low-grade squamous intraepithelial lesions (LSIL) after adequate colposcopic examination ruling out high-grade disease or cancer, LSIL on cytology, atypical squamous cells of undetermined significance, or normal cytology and a risk factor indicating a high probability of persistent infection with high-risk HPV (e.g. age .30 years, still positive on repeat Pap smear testing). Participants with high-grade squamous intraepithelial lesions were excluded from participation. Funding for the project came from an industry project aimed at developing a topical ointment for women with low-grade HPV-related disease. Thus, we accessed a population with low-grade disease as we developed the preliminary questionnaire.
Interview procedures
In open-ended interviews, a masters level study coordinator, trained in qualitative methods and cognitive interviewing techniques, used a semistructured interview guide to query participants on how they defined quality of life and the most important physical and psychological symptoms they experienced. After completing open-ended interviews, 20 participants provided an importance rating on items from the draft pool of items from the literature review and items from the FACIT database. We averaged these importance ratings and revised or dropped items based on these responses: items with low importance ratings were dropped. Item content (overlap with existing 4, 5, 20, 21 Lack of support 21 Lack of usual interests 18 Misunderstanding of available information 5, 22 Mood impairment 17 Pessimism 18 Poor concentration 18 Powerlessness 8 Self-blame 5, 8, 22, 23 Stigma, concealment of illness, panic 5, 8, 18, 22, 27, 28 Sleep disturbance 17, 18 Struggling with disclosure 5, 20, 22 Worry about risk of transmission 14, 22 HPV ¼ human papillomavirus items) and clinical relevance were also used to guide decision-making. After a draft measure was developed, a new set of 10 participants, recruited from the same clinic, completed cognitive interviews to help ensure that items would be understood as intended. 13 The study coordinator queried participants on the language, comprehensibility and relevance of the items. Both the open-ended and cognitive interviews were digitally recorded and transcribed verbatim. These qualitative data were then content analysed such that the study director (DR) and coordinator (RK) read and memoed the transcripts, identified prominent themes based on well accepted qualitative data coding procedures and came to consensus on themes through a series of discussions. 14 
RESULTS

Literature review
Nineteen articles in peer-reviewed journals were identified to help determine symptoms and concerns affecting people with HPV infection. Special effort was made to distinguish between disease-related and treatment-related problems. Final tabulation showed that 23 symptoms or concerns were documented (Table 1) .
Clinician survey
The symptoms and concerns identified provided a guide to selecting items for the measure. Items were selected from the FACIT item library, and the set of items were then reviewed by three clinician-investigators who were proficient in the diagnosis and treatment of patients with HPV infection. The clinicians completed a self-administered survey in which they provided an importance rating on 111 potential items. This information was then used to reduce the number to a 68 item pool.
Open-ended interviews
Twenty participants with cervical dysplasia provided selfreported sociodemographic and clinical information, completed open-ended interviews and gave importance ratings on the 68 items in the pool (see Tables 2 and 3 ). Psychosocial concerns were prominent themes that emerged from the interviews, as participants had particular concerns around embarrassment, disclosure, social support and anxiety. From information gathered in these interviews and importance ratings, we narrowed the pool to the 33 items that became the draft measure. In order to address participants' concerns about the future, the item 'I am hopeful about the future' was included. In order to address participants' concerns that their infection would become cancerous, we included the item 'I worry the infection will get worse,' which was worded more generally to be applicable for people with all types of HPV infection.
Cognitive interviews
Sociodemographic information for the cognitive interview participants is provided in (Table 4 ).
Overall, we began with 93 items that were reduced to 68 items based on expert review. Data from participants helped us to craft a more appropriate questionnaire. After incorporating participant importance ratings, the number items were dropped down to 33. Cognitive interview results suggested that we add questions to make the preliminary version of the scale contain 36 items.
DISCUSSION
Overall, a 36-item scale was constructed that assesses the health-related quality of life for women with low-grade cervical dysplasia. The scale sets out to assess both the physical and psychological consequences of cervical dysplasia, as well as general functionality (e.g. ability to work). This scale is distinct from other quality-of-life scales in that it is designed to be disease-specific, relevant for women with cervical dysplasia. It also goes beyond measuring psychological distress into other components of quality of life, including assessment of social relationships.
The study's primary limitation is that the participant sample included only women with low-grade disease. We excluded women with genital warts and high-grade disease, and as a result, further testing will be needed to determine whether the scale is appropriate for a broader population of women with HPV. Until more data are collected on the scale's internal and external validity, we advise that the scale be used with caution. Another limitation of the study was the fact that we do not assess participants' baseline knowledge of HPV infection (e.g. HPV is a sexually transmitted infection), which might have helped us to better understand emotional responses related to having cervical dysplasia.
The study was not designed to obtain psychometric or statistical data on the scale. However, we plan to study the measure's appropriateness for use with women with highgrade disease and genital warts as a consequence of HPV infection. We also plan to validate the scale by examining concurrent validity, conducting exploratory and confirmatory factor analysis, and performing reliability analyses. Prior to this validation study, the instrument should be used with caution and researchers perform psychometric test of their own. Once ours and other studies have established its psychometric properties, the scale will be well suited for use in clinical trials as well as clinical practice.
